| We need someone with experience http://whistlinjacklodge.com/chests-of-plenty-slots/ chests of plenty slot Boehringer added that a trend for overall survival benefit (8.0 months for the volasertib combo compared to 5.2 months for LDAC alone) was seen, while median event-free survival was 5.6 months in the former group compared to 2.3 months in the chemotherapy-alone arm. The encouraging results led to the initiation of a Phase III study.
|